Abstract

Background: The treatment of depression is a main strategy for suicide prevention in older adults. We aimed to calculate suicide rates by antidepressant prescription patterns in persons aged ≥ 75 years. A further aim was to estimate the contribution of antidepressants to the change in suicide rates over time.Methods: Swedish residents aged ≥ 75 years (N = 1,401,349) were followed between 2007 and 2014 in a national register-based retrospective cohort study. Biannual suicide rates were calculated for those with selective serotonin reuptake inhibitor (SSRI) single use, mirtazapine single use, single use of other antidepressants and use of ≥ 2 antidepressants. The contribution of antidepressants to the change in biannual suicide rates was analyzed by decomposition analysis.Results: There were 1,277 suicides. About one third of these were on an antidepressant during their last 3 months of life. In the total cohort, the average biannual suicide rate in non-users of antidepressants was 13 per 100,000 person-years. The corresponding figure in users of antidepressants was 34 per 100,000 person-years. These rates were 25, 42 and 65 per 100,000 person-years in users of SSRI, mirtazapine and ≥ 2 antidepressants, respectively. In the total cohort, antidepressant users contributed by 26% to the estimated increase of 7 per 100,000 in biannual suicide rates. In men, biannual suicide rates increased by 11 suicides per 100,000 over the study period; antidepressant users contributed by 25% of the change. In women, those on antidepressant therapy accounted for 29% of the estimated increase of 4.4 per 100,000.Conclusion: Only one third of the oldest Swedish population who died by suicide filled an antidepressant prescription in their last 3 months of life. Higher suicide rates were observed in mirtazapine users compared to those on SSRIs. Users of antidepressants accounted for only one quarter of the increase in the suicide rate. The identification and treatment of suicidal older adults remains an area for prevention efforts.

Highlights

  • The oldest segment of the population is accountable for the highest suicide rates in many countries [1]

  • Other studies reported lower rates of suicidal behavior in those treated with SSRI compared to other ADs [8], while those treated with mirtazapine had the highest suicide rates [8,9,10]

  • In a smaller study using a case-control design, we found no increase in suicide risk among older adult users of antidepressants compared to non-users, once we adjusted for relevant psychiatric disorders [32]

Read more

Summary

Introduction

The oldest segment of the population is accountable for the highest suicide rates in many countries [1]. Over one fifth of the Swedish population aged 75 and above is prescribed antidepressants (ADs), mainly SSRIs and mirtazapine [3]. Some research has found a higher suicide risk for persons initiating treatment with SSRI compared to other AD [7]. Others reported no difference [11] Such mixed results may be expected, given that suicide is a rare event and studies examined divergent populations and prescribing patterns. It remains unclear to what extent suicide rates vary in older people treated with different ADs [12, 13], or in those using multiple AD medications, which is a main therapeutic option for those with inadequate response to monotherapy [14]. We aimed to calculate suicide rates by antidepressant prescription patterns in persons aged ≥ 75 years. A further aim was to estimate the contribution of antidepressants to the change in suicide rates over time

Objectives
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call